Medtronic

Medtronic plc
Company type	Public limited company
Traded as	NYSE: MDT; S&P 100 component; S&P 500 component;
ISIN	IE00BTN1Y115
Industry	Medical equipment
Founded	1949
Headquarters	Dublin, Ireland (legal); Minneapolis, Minnesota, U.S. (operational);
Key people	Geoff Martha (Chairman & CEO); Karen L. Parkhill (CFO);
Products	Medical devices
Revenue	US$31.23 billion (2023)
Operating income	US$5.49 billion (2023)
Net income	US$3.76 billion (2023)
Total assets	US$90.95 billion (2023)
Total equity	US$51.48 billion (2023)
Number of employees	c. 95,000 (2023)
Website	medtronic.com
	Footnotes / references; Financials as of April 28, 2023

Medtronic plc is an American-Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.^[3]^[4] While it primarily operates in the United States,^[5]^[6] it operates in more than 150 countries and employs over 90,000 people.^[7] It develops and manufactures healthcare technologies and therapies.

^ ^a ^b "Locations". medtronic.com.
^ "Medtronic Plc 2023 Annual Report". U.S. Securities and Exchange Commission. 22 June 2023.
^ "Medtronic to buy Covidien for $42.9 billion, rebase in Ireland". Reuters. 16 June 2014. U.S. medical device maker Medtronic Inc (MDT.N) said on Sunday it had agreed to buy Covidien Plc COV.N for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.
^ Reilly, Mark (16 June 2014). "Medtronic will buy Covidien for $42.9 billion; HQ goes to Ireland, CEO stays here". www.bizjournals.com. Retrieved 25 October 2022.
^ Monique Ellis (30 May 2018). "The top 10 medical device companies". Proclinical. Medtronic is the top medical device company in the world for 2018 with an impressive annual revenue nearly $30 billion in 2017. The company experienced a 3% increase in revenue compared with 2016 figures and they reported 'balanced, diversified growth across all groups and regions'. Revenue increases are also due in part to the consolidation of its acquisition of Covidien.
^ Jonathan D. Rockoff; Nina Trentmann (11 February 2018). "New Tax Law Haunts Inversion Deals". Wall Street Journal.
^ Yu, Jea (27 July 2022). "Medtronic Stock Keeps Ticking Forward". Entrepreneur. Retrieved 19 October 2022.

[medtronic.com-1] "Locations". medtronic.com.

[10K-2] "Medtronic Plc 2023 Annual Report". U.S. Securities and Exchange Commission. 22 June 2023.

[cov-3] "Medtronic to buy Covidien for $42.9 billion, rebase in Ireland". Reuters. 16 June 2014. U.S. medical device maker Medtronic Inc (MDT.N) said on Sunday it had agreed to buy Covidien Plc COV.N for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.

[4] Reilly, Mark (16 June 2014). "Medtronic will buy Covidien for $42.9 billion; HQ goes to Ireland, CEO stays here". www.bizjournals.com. Retrieved 25 October 2022.

[largest-5] Monique Ellis (30 May 2018). "The top 10 medical device companies". Proclinical. Medtronic is the top medical device company in the world for 2018 with an impressive annual revenue nearly $30 billion in 2017. The company experienced a 3% increase in revenue compared with 2016 figures and they reported 'balanced, diversified growth across all groups and regions'. Revenue increases are also due in part to the consolidation of its acquisition of Covidien.

[wsj1-6] Jonathan D. Rockoff; Nina Trentmann (11 February 2018). "New Tax Law Haunts Inversion Deals". Wall Street Journal.

[7] Yu, Jea (27 July 2022). "Medtronic Stock Keeps Ticking Forward". Entrepreneur. Retrieved 19 October 2022.

[1]

[2]

[3]

[4]

[5]

[6]

[7]